G348-0679 Screening compound: N-ETHYL-2-{6-[(3-METHOXYPHENYL)METHYL]-11-DIOXO-1LAMBDA626-THIADIAZINAN-2-YL}-N-PHENYLACETAMIDE

G348-0679 Screening compound: N-ETHYL-2-{6-[(3-METHOXYPHENYL)METHYL]-11-DIOXO-1LAMBDA626-THIADIAZINAN-2-YL}-N-PHENYLACETAMIDE
G348-0679 Screening compound: N-ETHYL-2-{6-[(3-METHOXYPHENYL)METHYL]-11-DIOXO-1LAMBDA626-THIADIAZINAN-2-YL}-N-PHENYLACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound G348-0679
N-ETHYL-2-{6-[(3-METHOXYPHENYL)METHYL]-11-DIOXO-1LAMBDA626-THIADIAZINAN-2-YL}-N-PHENYLACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G348-0679

Molecular Formula

C21H27N3O4S (C21 H27 N3 O4 S)

Compound Name

N-ETHYL-2-{6-[(3-METHOXYPHENYL)METHYL]-11-DIOXO-1LAMBDA626-THIADIAZINAN-2-YL}-N-PHENYLACETAMIDE

IUPAC name

N-ethyl-2-{6-[(3-methoxyphenyl)methyl]-11-dioxo-1lambda626-thiadiazinan-2-yl}-N-phenylacetamide

SMILES

CCN(C(CN(CCCN1Cc2cc(OC)ccc2)S1(=O)=O)=O)c1ccccc1

InChI

InChI=1S/C21H27N3O4S/c1-3-24(19-10-5-4-6-11-19)21(25)17-23-14-8-13-22(29(23,26)27)16-18-9-7-12-20(15-18)28-2/h4-7,9-12,15H,3,8,13-14,16-17H2,1-2H3

InChI Key

QFFXYJJKESAIGP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27136738

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.53

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.468

Distribution Coefficient, logD

2.468

Water Solubility, LogSw

-2.73

Polar Surface Area

59.014

Acid Dissociation Constant (pKa)

23.73

Base Dissociation Constant (pKb)

-0.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.10

G348-0679 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G348-0679 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G348-0679?
Check Price and Availability of G348-0679, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G348-0679 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G348-0679
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G348-0679
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G348-0679 available by request